Drug Profile
E 5505
Latest Information Update: 05 Dec 2006
Price :
$50
*
At a glance
- Originator Esteve
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 23 Oct 1998 Phase-I clinical trials for Depression in United Kingdom (Unknown route)